Stevens, Claire
Vrinten, Charlotte
Smith, Samuel G.
Waller, Jo
Beeken, Rebecca J. http://orcid.org/0000-0001-8287-9351
Funding for this research was provided by:
Cancer Research UK (CRUK) (C416/A19488, C1418/A14134, C7492/A17219)
Yorkshire Cancer Research (L389SS, L389RB)
Article History
Received: 19 January 2018
Revised: 31 May 2018
Accepted: 4 June 2018
First Online: 11 July 2018
Competing interests
: The authors declare no competing interests.
: Data will be made available to other researchers after the acceptance for publication of the main findings of the ABACUS survey. Data requests will be assessed on a case-by-case basis. Users will be required to complete a data sharing agreement.
: Included patients had previously signed written informed consent regarding the anonymous publication of their clinico-pathological data for translational research purposes.
: C.S. is supported by a Cancer Research UK PhD Studentship (C416/A19488). C.V. is supported by a programme grant from Cancer Research UK awarded to Professor Jane Wardle (C1418/A14134). J.W. is funded by a Cancer Research UK career development fellowship (grant reference: C7492/A17219). R.J.B. and S.G.S. are supported by Yorkshire Cancer Research University Academic Fellowship funding (L389RB and L389SS).
: Ethical approval was granted by the UCL Research Ethics Committee (Ref: 5771/002). Consent to participate was sought by market research company Taylor Nelson Sofres (TNS).